Catalyst Wire Dossier Catalyst Wire Dossier

Lenacapavir (Sunlenca)

Lenacapavir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenacapavir (Sunlenca), covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County

See pricing